New Blood Test Detects Neurogenerative Disease; Offers Hope For Earlier Treatment
Test pinpoints key markers for Alzheimer’s, Parkinson’s, MS, and concussions
Labcorp has launched a new blood test that has the potential to treat brain diseases and injury more effectively through early detection.
You may also be interested in...
During a webinar hosted by the Alliance for a Stronger FDA, the US agency’s Deputy Commissioner Janet Woodcock discussed the FDA’s efforts to modernize how it collects and analyzes data.
While half of all medical devices in the US are sterilized with ethylene oxide, emissions from the gas pose potential environmental hazards that are attracting federal action.
The US FDA is now allowing users to submit 510(k), PMA, and other premarket applications through its Customer Collaborations Portal, which previously only allowed users to track submissions.